Successful treatment with bosentan for severe digital ischaemia in limited cutaneous systemic sclerosis [2]

Annals of the Rheumatic Diseases

Volumn 66, Issue 8, 2007, Pages 1122-1123

  Yu, Emma P K ^a   Ostor, Andrew J K ^a   Hall, Frances C ^b  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BOSENTAN; CLOPIDOGREL; FLUOXETINE; ILOPROST; LANSOPRAZOLE; LOSARTAN; NIFEDIPINE;

ADULT; BLOOD TRANSFUSION; CASE REPORT; CLINICAL FEATURE; DOSE RESPONSE; DRUG DOSE INCREASE; FINGER ISCHEMIA; GASTRITIS; HUMAN; ISCHEMIA; LABORATORY TEST; LETTER; LIMITED CUTANEOUS SYSTEMIC SCLEROSIS; MALE; PRIORITY JOURNAL; RADIODIAGNOSIS; SYSTEMIC SCLEROSIS; TREATMENT OUTCOME;

ADULT; FINGERS; HUMANS; ISCHEMIA; MALE; SCLERODERMA, LIMITED; SULFONAMIDES; VASODILATOR AGENTS;

EID: 34547205606     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2006.057604     Document Type: Letter

References (7)

1. Herrick AL. Pathogenesis of Raynaud's phenomenon. Rheumatology 2005;44:587-96.
2. Kahaleh MB. Raynaud phenomenon and the vascular disease in scleroderma. Curr Opin Rheumatol 2004;16:718-22.
3. Jeffery TK, Wanstall JC. Pulmonary vascular remodelling: a target for therapeutic intervention in pulmonary hypertension. Pharmacol Ther 2001;92:1-20.
4. Humbert M, Sitbon O, Simonneau G. Treatment of pulmonary arterial hypertension. N Engl J Med 2004;351:1425-36.
5. McLaughlin VV, Sitbon O, Badesch DB, Barst RJ, Black C, Galiè N, et al. Survival with first-line bosentan in patients with primary pulmonary hypertension. Eur Respir J 2005;25:244-9.
6. Williams MH, Das C, Handler CE, Akram MR, Davar J, Denton CP, et al. Systemic sclerosis associated pulmonary hypertension: improved survival in the current era. Heart 2006;92:926-32.
7. Korn JH, Mayes M, Matucci CM, Rainisio M, Pope J, Hachulla E, et al. Digital ulcers in systemic sclerosis: prevention by treatment with bosentan, an oral endothelin receptor antagonist. Arthritis Rheum 2004;50:3985-93.